Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective treatment options for obesity
Regulators focus on substance, use, and context rather than disclaimers
Winner: Sermorelin takes the affordability crown at $150-200 monthly for standard dosing
Yet it also comes with nausea, constipation, bloating and even sometimes diarrhea, which appear in a high percentage of patients
All three are GHRPs acting through the ghrelin receptor to stimulate pituitary GH release, but their side-hormone profiles differ significantly
These include nausea, vomiting, stomach discomfort, and a reduced appetite
US$ 20.12
US$ 26.48
US$ 21.10
